the anticipatory rise in category-selective activity shown in Fig. 2 (figs. S10 and S11). Taken together, these results suggest that including voxels outside of the peak categoryselective ROIs improves our ability to detect subtle changes in the reinstatement of category-related activity.
The work described here is one of a growing number of fMRI studies illustrating the benefits of multivoxel pattern-classification techniques (17-20, 25, 26) . These studies have demonstrated that, by efficiently extracting the information present in multivoxel patterns of brain activity, it is possible to detect subtle distinctions between cognitive states using relatively thin time slices of brain data (on the order of seconds). Whereas previous applications of classification techniques have focused on brain activity elicited by specific perceptual cues, our study shows that classification algorithms can be used to extract a time-varying trace of the subjects_ cognitive state as they search through memory in the absence of specific cues. Our results ground Tulving_s speculations about mental time travel in neural fact. As subjects search for memories from a particular event, their brain state progressively comes to resemble their brain state during the sought-after event, and the degree of match predicts what kinds of information the subjects will retrieve. By providing a direct view of how subjects are cueing memory, the methods presented here constitute a powerful new tool that researchers can use to test and refine theories of how people mine the recesses of the past. 21 . Materials and methods-including behavioral paradigm, scanning parameters, classifier methods, data preprocessing details, details regarding nonparametric statistics, and details of map creation-are available as supporting material on Science Online. 22 . N. Kanwisher, J. McDermott, M. M. Chun, J. Neurosci. 17, 4302 (1997) . 23 . R. Epstein, N. Kanwisher, Nature 392, 598 (1998). 24 . A listing of the brain regions that were most reliably activated by each study context across subjects (as identified by a group general linear model analysis) is available (21) . 25. Y. Kamitani, F. Tong, Nat. Neurosci. 8, 679 (2005) . 26. J. D. Haynes, G. Rees, Nat. Neurosci. 8, 686 (2005) . 27. When computing the correlation between classifier estimates and recall behavior, we adjusted for the hemodynamic response in two ways. In our primary analysis, we shifted the recall record forward by three time points (as in Fig. 1 ). We also ran a secondary analysis, where we convolved the recall record with a model of the hemodynamic response. The two analyses yielded very similar results (21 Cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) are two major inflammatory mediators. Here we show that iNOS specifically binds to COX-2 and S-nitrosylates it, enhancing COX-2 catalytic activity. Selectively disrupting iNOS-COX-2 binding prevented NO-mediated activation of COX-2. This synergistic molecular interaction between two inflammatory systems may inform the development of anti-inflammatory drugs.
Inflammatory processes are mediated by multiple molecular mechanisms. Two of the most prominent are the production of nitric oxide (NO) by inducible NO synthase (iNOS) and the formation of prostaglandins by cyclooxygenase-2 (COX-2; prostaglandin H 2 synthase) (1, 2). COX-2 inhibitors have attained widespread use as anti-inflammatory agents, although they elicit potentially adverse side effects (1, 3, 4) , whereas iNOS inhibitors are not presently employed therapeutically. Inflammatory stimuli elicit the synthesis of iNOS and COX-2 proteins with similar time courses, which suggests that the two systems may interact (5, 6) . Stimulants of iNOS such as bradykinin (7) and lipopolysaccharide (LPS) plus interferon-g (IFN-g), two components of endotoxin, enhance prostaglandin formation (8) . NOS inhibitors prevent the formation of prostaglandins (9) .
To determine whether iNOS and COX-2 interact, we used a murine macrophage cell line (RAW264.7) in which LPS and IFN-g massively activate both iNOS and COX-2. INOS immunoprecipitated with COX-2-specific antibodies from lysates of cells treated with LPS-IFN-g ( Fig. 1A) . This was also observed in transfected human embryonic kidney cells (HEK293T) overexpressing both proteins ( fig. S1A ). The two enzymes also coimmuno-precipitated from peritoneal macrophages obtained from mice injected with thioglycollate, an inflammatory stimulus that induces peritonitis or pleuritis (fig. S1B). To determine whether catalytic activity of the enzymes influences their interactions, cells that were induced by LPS-IFN-g were also treated with the iNOSselective inhibitor 1400W ( Fig. 1B) or the COX-2-selective inhibitor SC58125 (Fig. 1C ). Coimmunoprecipitation of iNOS and COX-2 by antibodies specific to either protein was unaffected by either inhibitor. The binding of iNOS and COX-2 was selective, because COX-1 did not immunoprecipitate with iNOS. To map the binding sites on both proteins, we generated selective deletions of iNOS ( Fig. 1 , D to F) and COX-2 ( Fig. 1 , G and H) sequences. The amino acid segment 1 to 144 of iNOS, which is within the oxygenase domain, is required, whereas the C terminus of COX-2 mediates binding and includes amino acids 484 to 604, which do not exist in COX-1.
The two major mechanisms whereby NO influences its intracellular targets are stimulation of guanylyl cyclase by direct binding of NO to iron in heme at the active site of guanylyl cyclase (10) or S-nitrosylation of protein targets on appropriate cysteines (11, 12) . Because COX-2 has heme at its active site (13) , this would be a potential target. However, NO binding to heme in COX-1 does not alter its activity (14) . COX-2 also contains 13 cysteines whose roles are not fully understood (15) . To explore the possibility of S-nitrosylation of COX-2 by NO, we examined multiple NO donors including nitroso-S-glutathione (GSNO) ( Fig. 2A ), sodium nitroprusside (SNP), spermine-NO, and S3A ). Using the biotin switch method in which all the S-nitrosylated cysteines are selectively biotinylated (16) , we observed that all four NO donors elicited S-nitrosylation of COX-2 in transfected HEK293T cells expressing COX-2-Myc ( Fig. 2A ). S-Nitrosylation of COX-2 was also observed in RAW264.7 cells treated with LPS-IFN-g. This was prevented when cells were treated with iNOS inhibitor 1400W ( Fig. 2B and fig. S3B ). The biotin switch method was specific, as H 2 O 2 did not elicit S-nitrosylation ( fig. S4 ). We also ruled out the possibility that sulfenic acid modification was detected by the biotin switch assay by demonstrating that arsenite, which reverses sulfenic acid modifications but not S-nitrosylation, failed to provide the biotin switch signal afforded by ascorbate using GSNO with purified COX-2 or LPS-IFN-g treatment of RAW 264.7 cells ( fig. S4B ). In some instances there may be no need to deliver NO directly to targets, as some actions of NO are prevented by hemoglobin, which sequesters freely diffusible NO (17) . We examined the effects of hemoglobin on S-nitrosylation of COX-2 under varying conditions. In transfected HEK293T cells expressing COX-2, hemoglobin prevented the S-nitrosylation elicited by GSNO ( fig. S5A ), whereas it failed to alter S-nitrosylation of COX-2 in RAW264.7 cells activated by LPS-IFN-g ( fig. S5B ). Thus, in the more physiologic macrophage cell line, the S-nitrosylation of COX-2 induced by an inflammatory stimulus does not appear to be elicited by freely diffusible NO.
To determine whether S-nitrosylation of COX-2 alters enzyme activity, we examined transfected HEK293T cells expressing COX-2-Myc. The NO donor SNP, added to cell lysates, elicited a twofold increase in COX-2 activity, reflecting S-nitrosylation. Ascorbic acid reversed S-nitrosylation (16, 18) and prevented the increase (Fig. 2 , C and D). The reversal by ascorbate of COX-2 activation by NO donors is not merely a reflection of ascorbate influences on enzyme substrates or intermediate products, as ascorbate failed to affect COX-2 activity in preparations not treated with SNP. Further evidence that S-nitrosylation and COX-2 activation are related is the closely similar concentrationresponse relation between the effects of the NO donor GSNO on S-nitrosylation and on COX-2 activity ( Fig. 2E) .
NO activates COX-2 by increasing its apparent V max without changing its K m (Fig. 2F ). The higher concentration of SNP required to activate COX-2 in vitro compared with intact cells accords with earlier studies showing greater potency of NO donors in intact cells (19) . To ascertain the kinetic basis for NO activation of COX-2, we conducted enzyme assays with increasing concentrations of sucrose to augment viscosity and slow down enzyme kinetics ( Fig.  2G ). As expected, with increasing viscosity, the ratio of control enzyme activity to the activity in more viscous solutions increased. This increase was diminished in SNP samples, consistent with SNP_s accelerating the release of product from the enzyme.
To determine which of the 13 cysteines of COX-2 are critical for the augmentation of COX-2 activity elicited by S-nitrosylation, To ascertain which of these three cysteines is responsible for augmented COX-2 activity, each was mutated to serine. The mutation in which Ser is substituted for Cys 526 (C526S) prevented activation of COX-2 by the NO donor SNP, whereas the C561S mutation did not ( fig. S6 ). least three independent determinations, each in triplicate (*statistically significant by Student's t test). (B) Combinations of L-NAME (500 mM), L-NAME þ L-Arg (1 mM) or D-Arg (1 mM), and D-NAME (500 mM) were added to RAW264.7 cells treated with LPS-IFN-g. PGE 2 was measured. The data were pooled from three independent experiments performed, each in triplicate. (C) PGE 2 and nitrite were measured from primary peritoneal macrophages isolated from wild-type (WT) or iNOS knockout (KO) mice. Macrophages were treated with LPS-IFN-g or untreated (*statistically significant by Student's t test). (D) S-Nitrosylation of COX-2 of WT primary peritoneal macrophages treated with LPS-IFN-g is abolished in iNOS KO macrophages. All the S-nitrosylated proteins were precipitated, and COX-2 was detected by Western blot with COX-2-specific antibody.
The C555S mutation abolished enzyme activity, so the effects of NO stimulation could not be assessed. Individual mutation of the 13 cysteines in COX-2 did not detectably diminish total S-nitrosylation of the enzyme, which suggests that multiple cysteines can be S-nitrosylated, but only C526 is responsible for enzyme activation by NO.
To clarify the influence of NO on prostaglandin E 2 (PGE 2 ), a prostaglandin synthesized by COX-2 formation in a physiologic context, we examined RAW264.7 cells. The formation of PGE 2 in response to LPS-IFN-g was inhibited by the iNOS inhibitor 1400W, with 50% reduction of PGE 2 formation at drug concentrations that provide 50% inhibition of iNOS activity (Fig. 3A) . Specificity of the NO association was evident by inhibition of PGE 2 formation with the active L-isomer of the NOS inhibitor N-nitro-L-arginine methyl ester (L-NAME) but not by D-NAME; the effects of L-NAME were reversed by added L-arginine (Fig. 3B) . Thus, about 50% of induced COX-2 activity is determined by S-nitrosylation.
As RAW264.7 cells are a continuous macrophage cell line that may not behave the same as macrophages in intact organisms, we used peritoneal macrophages from mice lacking iNOS. PGE 2 formation from macrophages of mice treated with LPS-IFN-g was reduced in the iNOS knockout mice by È70%, in parallel with a similar reduction in nitrite formation by the macrophages (Fig. 3C ) and a decrease in S-nitrosylated COX-2 (Fig. 3D) . These observations concur with findings of decreased urinary PGE 2 in iNOS knockout mice (20) .
We hypothesized that the increase in PGE 2 formation by iNOS activation reflects binding of iNOS to COX-2 to deliver NO in appropriate proximity for S-nitrosylation. To explore this possibility we blocked iNOS-COX-2 binding with the fragment of COX-2 (amino acids 484 to 604), which binds iNOS (Fig. 4A) . Expression of COX-2(484-604) in transfected RAW264.7 cells abolished the coprecipitation of iNOS and COX-2. Instead, COX-2(484-604) associated with iNOS ( Fig. 4A) . Moreover, this interference of binding between COX-2 and iNOS by COX-2(484-604) decreased S-nitrosylation of COX-2 in RAW264.7 cells (Fig. 4B) . The dominant-negative effect of COX-2(484-604) reduced PGE 2 formation by more than 50%, whereas expression of a COX-2 fragment of amino acids 1 to 483, which does not bind iNOS, failed to influence PGE 2 formation (Fig. 4, C and D) .
In summary, our study establishes a physiologic binding interaction of iNOS and COX-2 bringing NO in proximity to COX-2, facilitating its S-nitrosylation and activation, and fitting with earlier findings that NOS inhibition decreases prostaglandin formation (9, 21) . Our findings accord with recent evidence that many physiologic actions of NO require its delivery to molecular targets (12, 22, 23) . Whereas scaffolding proteins such as CAPON (22) or PSD95 (23) link neuronal NOS, respectively, to Dexras1 (22) and N-methyl-D-aspartate receptors (23), iNOS and COX-2 bind directly. The molecular synergism between iNOS and COX-2 may represent a major mechanism of inflammatory responses. Drugs that block the iNOS-COX-2 interaction may be anti-inflammatory, synergizing with COX-2 inhibitors and permitting lower doses. As the binding site on iNOS is in the catalytic domain, derivatives of iNOS inhibitors that also prevent binding to COX-2 may decrease both NO and prostaglandin formation. Instead of the immunoglobulin-type antigen receptors of jawed vertebrates, jawless fish have variable lymphocyte receptors (VLRs), which consist of leucinerich repeat (LRR) modules. Somatic diversification of the VLR gene is shown here to occur through a multistep assembly of LRR modules randomly selected from a large bank of flanking cassettes. The predicted concave surface of the VLR is lined with hypervariable positively selected residues, and computational analysis suggests a repertoire of about 10 14 unique receptors. Lamprey immunized with anthrax spores responded with the production of soluble antigen-specific VLRs. These findings reveal that two strikingly different modes of antigen recognition through rearranged lymphocyte receptors have evolved in the jawless and jawed vertebrates.
An adaptive immune system based on lymphocytes bearing clonally diverse antigenspecific receptors first appeared at the dawn of vertebrate evolution È500 million years ago. Within less than 40 million years in the Cambrian, both jawless and jawed vertebrates evolved mechanisms of lymphocyte receptor diversification that were radically different. Thus, jawed vertebrates rearrange immunoglobulin and T cell receptor (TCR) variable, diverse, and joining gene segments (VDJs) to generate highly diverse repertoires of T and B lymphocyte antigen receptors (1, 2) . In contrast, lamprey and hagfish, jawless fish representatives of the oldest vertebrate taxon, assemble their VLRs from modular LRR units (3, 4) . In the lamprey, a single incomplete germline VLR gene generates a diverse repertoire of cell surface receptors through somatic rearrangement of LRR cassettes that flank the gene. Each lymphocyte thus assembles a VLR gene of unique sequence. Hagfish have two germline VLR genes, called VLR-A and VLR-B, that can generate equivalently diverse receptor repertoires (4). On the basis of the existence of a sizable repertoire of diverse lymphocyte receptors, we hypothesized that VLRs may serve as jawless fish equivalents of the anticipatory antigen receptors of jawed vertebrates. The potential diversity of lamprey VLRs was estimated by analysis of 517 unique VLR sequences, including 129 previously reported sequences (3) and 388 new sequences derived mostly from animals immunized with the Bacillus anthracis spore coat (5) . Analysis of the aligned VLR diversity regions revealed mixed clusters of sequences, with no exclusive clustering of VLRs from animals immunostimulated with particular antigens. The alignment was then converted into a matrix consisting of the individual types of constituent LRR modules (Fig. 1A) . This included the 30 to 38 residue N-terminal LRR (LRRNT), 18-residue first LRR (LRR1), 24-residue LRRs (LRRVs), 13-residue connecting peptide (CP), and 48to 65-residue C-terminal LRR (LRRCT). Noting that the terminal 24-residue LRR module adjacent to the CP had a distinct sequence signature in 98% of the cases (fig. S1) (5), we designated this as the LRRV-end (LRRVe).
The data set was screened for repetitive occurrence of each type of LRR module, singly or as recurring pairs (Tables 1 and 2 ). Most pairs of adjoining LRRVs or LRRVe_s were only observed once, but in some cases, repetitious pairs of LRRNT-LRR1 and CP-LRRCT were identified. These may represent VLRs that were assembled from multimodule genomic cassettes, such as one LRR1-LRRV-LRRV triplet previously identified in the VLR locus (3), or VLRs selected for certain structural conformations. However, 94% of the LRRNT-LRR1 and CP-LRRCT pairs are either unique or consist of the same pair of adjoining modules occurring three times or less in the VLR data set, and the pairing occurrence follows a random Poisson distribution (6) . Most hagfish VLR-A modules were also found in random combinations (n 0 139; tables S1 and S2), whereas the VLR-B sample (n 0 70) was too small for reliable analysis. The potential diversity of the VLR repertoire was therefore calculated by considering individual LRR modules as independent recombination units. For the lamprey, we predict a potential repertoire of up to 10 14 unique VLRs and up to 10 17 for the hagfish VLR-A (5) .
The number of LRR cassettes flanking the germline VLR gene is unknown. Thus far, 32 unique germline LRR modules have been identified in the partially sequenced lamprey VLR locus (3), and only 15 of these were identical to one of the 1568 modules from the VLR data set. To estimate the number of LRRV modules in flanking cassettes at the VLR locus, we used Monte Carlo simulations to predict at 95% confidence level an upper bound estimate of È1500 lamprey LRRVs and È2400 LRRVs for the hagfish VLR-A (5). These data suggest that the rearrangement process that yields mature VLR genes occurs by random selection of each module type from a large pool of genomic LRR modules.
The lamprey germline VLR gene of È13 kb consists of three coding regions separated by two intervening sequences: (i) the signal peptide and 5 ¶ portion of LRRNT, (ii) the 5 ¶ portion of LRRCT, and (iii) the 3 ¶ portion of LRRCT
